US Stock MarketDetailed Quotes

VTGN VistaGen Therapeutics

Watchlist
  • 3.5200
  • 0.00000.00%
Close Jun 14 16:00 ET
  • 3.3900
  • -0.1300-3.69%
Post 18:31 ET
95.13MMarket Cap-2315P/E (TTM)

VistaGen Therapeutics Key Stats

VistaGen Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2024 Earnings

Jun 11, 2024

Revenue(YoY)

197.30K

+12.17%
EPS(YoY)

-0.35

+79.15%

Buy

May 31, 2024

VistaGen Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 99.000K--
--2025/Q1-- / 298.500K--
Jun 11, 20242024/Q4197.300K / 202.750K--
Feb 13, 20242024/Q3411.400K / 544.500K--
Nov 9, 20232024/Q2277.700K / 0.000--
Aug 10, 20232024/Q1177.600K / 0.000--
Jun 28, 20232023/Q4175.600K / 0.000--
Feb 7, 20232023/Q3179.600K / 310.000K--
Nov 10, 20222023/Q2-892.500K / 206.700K--
Aug 11, 20222023/Q1310.100K / 238.630K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 99.000K--
--2025/Q1-- / 298.500K--
Jun 11, 20242024/Q4197.300K / 202.750K--
Feb 13, 20242024/Q3411.400K / 544.500K--
Nov 9, 20232024/Q2277.700K / 0.000--
Aug 10, 20232024/Q1177.600K / 0.000--
Jun 28, 20232023/Q4175.600K / 0.000--
Feb 7, 20232023/Q3179.600K / 310.000K--
Nov 10, 20222023/Q2-892.500K / 206.700K--
Aug 11, 20222023/Q1310.100K / 238.630K--

Unlock Free Earnings Estimates

VistaGen Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 31, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg